Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-071172

Director sold 300 shares at $9.73 ($2,920)

  • Director acquired 10,452 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Christian Waage Director 2021-12-21 Sale −300 $9.73 $2,920 3,200 D: show line 1 in the form
Christian Waage Director 2021-12-22 Grant or award +10,452 13,652 D: show line 2 in the form
Open-market sales · 300 sh · avg $9.73 · $2,920

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Christian Waage Director 2021-12-22 Grant or award · Stock Option (Right to Buy) +20,903 20,903 D: show line 3 in the form
Loading xslF345X03/doc4.xml…